We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+17.25%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$354M
AUM Growth
+$43.2M
Cap. Flow
+$30.3M
Cap. Flow %
8.54%
Top 10 Hldgs %
31.72%
Holding
1,674
New
354
Increased
213
Reduced
237
Closed
746

Top Buys

Rank Stock Value
1
CDTX
Cidara Therapeutics
CDTX
+$23.5M
2
BMO icon
Bank of Montreal
BMO
+$13.2M
3
MPWR icon
Monolithic Power Systems
MPWR
+$10.1M
4
SILJ icon
Amplify Junior Silver Miners ETF
SILJ
+$9.5M
5
COPX icon
Global X Copper Miners ETF NEW
COPX
+$8.61M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.8M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$4.39M
3
MSFT icon
Microsoft
MSFT
+$3.76M
4
SGML icon
Sigma Lithium
SGML
+$3.53M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 20.04%
2 Financials 17.75%
3 Technology 15.74%
4 Industrials 7.52%
5 Consumer Discretionary 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVH icon
551
Evolent Health
EVH
$527M
$20K 0.01%
5,000
-17,632
-78% -$98K
NEU icon
552
NewMarket
NEU
$8.72B
$20K 0.01%
30
– –
SNOW icon
553
Snowflake
SNOW
$117B
$20K 0.01%
94
-6,863
-99% -$1.68M
ZETA icon
554
Zeta Global
ZETA
$7.44B
$20K 0.01%
1,030
+1,016
+7,257% +$19K
CTRI icon
555
Centuri Holdings
CTRI
$2.33B
$20K 0.01%
+800
New +$17.9K
HCMA
556
HCM III Acquisition Corp
HCMA
$20K 0.01%
+2,000
New +$20.4K
DB icon
557
Deutsche Bank
DB
$72.1B
$19K 0.01%
500
– –
INBX icon
558
Inhibrx
INBX
$1.42B
$19K 0.01%
250
– –
UNF icon
559
Unifirst Corp
UNF
$5.21B
$19K 0.01%
+100
New +$16.9K
WPC icon
560
W.P. Carey
WPC
$16.3B
$19K 0.01%
300
-7,200
-96% -$479K
WSBC icon
561
WesBanco
WSBC
$4.1B
$19K 0.01%
600
– –
BULL
562
Webull Corp
BULL
$4.23B
$19K 0.01%
2,500
-42,500
-94% -$427K
AAP icon
563
Advance Auto Parts
AAP
$3.46B
$18K 0.01%
470
+355
+309% +$17.8K
COP icon
564
ConocoPhillips
COP
$150B
$18K 0.01%
+200
New +$18.1K
CRBG icon
565
Corebridge Financial
CRBG
$15.3B
$18K 0.01%
620
+190
+44% +$5.84K
DVN icon
566
Devon Energy
DVN
$48.8B
$18K 0.01%
500
-182
-27% -$6.35K
HIVE
567
HIVE Digital Technologies
HIVE
$706M
$18K 0.01%
7,000
+2,770
+65% +$11.7K
HUT
568
Hut 8
HUT
$10.2B
$18K 0.01%
413
-1,293
-76% -$57K
NJR icon
569
New Jersey Resources
NJR
$5.64B
$18K 0.01%
400
– –
PACB icon
570
Pacific Biosciences
PACB
$357M
$18K 0.01%
10,000
-10,000
-50% -$19.2K
PI icon
571
Impinj
PI
$5.46B
$18K 0.01%
104
-169
-62% -$30.1K
PZZA icon
572
Papa John's
PZZA
$804M
$18K 0.01%
490
-13,370
-96% -$591K
SE icon
573
Sea Limited
SE
$75.5B
$18K 0.01%
+142
New +$21K
XTIA icon
574
XTI Aerospace
XTIA
$60.4M
$18K 0.01%
+15,000
New +$22K
AVIR icon
575
Atea Pharmaceuticals
AVIR
$406M
$17K ﹤0.01%
5,000
– –
21 22
23
24 25

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

FNY Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, FNY Investment Advisers held 1,674 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FNY Investment Advisers deployed $30.3M of net new capital in Q4 2025, opening 354 new positions and adding to 213 existing holdings. Its largest new stake was Cidara Therapeutics: 145,533 shares worth $32.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Sibanye-Stillwater, an estimated $4.39M trimmed.

  • FNY Investment Advisers's largest Q4 2025 buy was Cidara Therapeutics: 145,533 shares worth $32.1M.
  • FNY Investment Advisers added most to Morgan Stanley in Q4 2025, an estimated $6.17M increase.
  • FNY Investment Advisers's biggest Q4 2025 reduction was Sibanye-Stillwater, cutting an estimated $4.39M.
  • FNY Investment Advisers fully exited Verona Pharma in Q4 2025, selling an estimated $15.8M.
  • FNY Investment Advisers's ten largest holdings make up 32% of its $354M portfolio in Q4 2025.
  • FNY Investment Advisers opened 354 new positions and closed 746 in Q4 2025.
  • FNY Investment Advisers's portfolio value rose 14% quarter-over-quarter to $354M.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.